FDA Issues Warning Letters to Drugmaker, Diagnostics Firm for GMP
28 May 2025 //
RAPS
AACE Pharma`s Generic Methscopolamine Bromide Receives Approval in the U.S.
01 Feb 2024 //
FDA
AACE`s Generic Metolazone Receives Approval in the U.S.
25 Oct 2022 //
FDA